Elizabeth Garrett-Mayer to Maximum Tolerated Dose
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Maximum Tolerated Dose.
Connection Strength
0.300
-
Dose-finding clinical trial design for ordinal toxicity grades using the continuation ratio model: an extension of the continual reassessment method. Clin Trials. 2012 Jun; 9(3):303-13.
Score: 0.097
-
Proportional odds model for dose-finding clinical trial designs with ordinal toxicity grading. Stat Med. 2011 Jul 30; 30(17):2070-80.
Score: 0.089
-
The continual reassessment method for dose-finding studies: a tutorial. Clin Trials. 2006; 3(1):57-71.
Score: 0.062
-
Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma. Cancer. 2009 Jun 01; 115(11):2514-22.
Score: 0.020
-
Pharmacodynamic-guided modified continuous reassessment method-based, dose-finding study of rapamycin in adult patients with solid tumors. J Clin Oncol. 2008 Sep 01; 26(25):4172-9.
Score: 0.019
-
A phase I toxicity and feasibility trial of sequential dose-dense induction chemotherapy with doxorubicin, paclitaxel, and 5-fluorouracil followed by high dose consolidation for high-risk primary breast cancer. Breast Cancer Res Treat. 2002 Nov; 76(2):145-56.
Score: 0.013